Fundz

Tris Pharma

Monmouth Junction, New Jersey, United States · Healthcare, Pharmaceutical Manufacturing

Tris Pharma, Inc. is a leading privately-owned biopharmaceutical company in the U.S. Our focus is on the development and commercialization of innovative medicines that address unmet patient needs and we have more than 150 U.S. and International patents including applications. We market several branded and generic products in the U.S; license our products in the U.S. and international markets and

Key facts

Headquarters
Monmouth Junction, New Jersey, United States
Employees
Unknown
Industries
Healthcare, Pharmaceutical Manufacturing
Status
Private
Website
trispharma.com
LinkedIn
Company page

Recent activity at Tris Pharma

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Tris Pharma funding history

DateRoundAmount
Oct 2018Venture$125.0M

Leadership

  • Ketan Mehta, Executive Officer, Director
  • Smita Mehta, Director
  • Franchesca Fowler, Chief Compliance Officer
  • Peter Ciano, Executive Officer

Verified email and direct lines for Tris Pharma’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Employee benefit plans

Tris Pharma files 5 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Tris Pharma in the news

Companies similar to Tris Pharma

About Tris Pharma: questions and answers

What does Tris Pharma do?

Tris Pharma, Inc. is a leading privately-owned biopharmaceutical company in the U.S. Our focus is on the development and commercialization of innovative medicines that address unmet patient needs and we have more than 150 U.S. and International patents including applications. We market several branded and generic products in the U.S; license our products in the U.S. and international markets and

Where is Tris Pharma headquartered?

Tris Pharma is headquartered in Monmouth Junction, New Jersey, United States.

Has Tris Pharma raised funding?

Yes. Fundz has recorded 1 funding event for Tris Pharma. The most recent, $125.0M, was in Oct 2018.

What is the latest news on Tris Pharma?

On Jan 22, 2025, Tris Pharma Announces Positive Results for Cebranopadol in Treating Acute Pain

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Tris Pharma across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.